In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed for people with Type 2 diabetes or pre-diabetes who are not using insulin. The corresponding app offers readouts, showing when users’ glucose levels spike and ebb throughout the day. “When someone sees their own personal data, that’s empowering, because they can do something about it,” says COO Jake Leach. Indeed, the app helps teach users how to minimize glucose spikes, by, say, eating fiber first during meals or taking a walk straight after eating.
Buy Now: Glucose Biosensor on Stelo
More Must-Reads from TIME
- Donald Trump Is TIME's 2024 Person of the Year
- Why We Chose Trump as Person of the Year
- Is Intermittent Fasting Good or Bad for You?
- The 100 Must-Read Books of 2024
- The 20 Best Christmas TV Episodes
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- Merle Bombardieri Is Helping People Make the Baby Decision
Contact us at letters@time.com